Home
ASTH
ASTH News

Latest Astrana Health Inc. Common Stock (ASTH) News on October 17, 2025

1 of Wall Street’s Favorite Stock to Keep an Eye On and 2 We Find Risky

StockStory

10 days ago

1 of Wall Street’s Favorite Stock to Keep an Eye On and 2 We Find Risky

1 Value Stock to Research Further and 2 We Find Risky

StockStory

14 days ago

1 Value Stock to Research Further and 2 We Find Risky

1 Volatile Stock on Our Watchlist and 2 We Ignore

StockStory

16 days ago

1 Volatile Stock on Our Watchlist and 2 We Ignore

Integer Holdings, Astrana Health, Surgery Partners, IQVIA, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know

StockStory

2 months ago

Integer Holdings, Astrana Health, Surgery Partners, IQVIA, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know

5 Must-Read Analyst Questions From Astrana Health’s Q1 Earnings Call

StockStory

4 months ago

5 Must-Read Analyst Questions From Astrana Health’s Q1 Earnings Call

Prospect Medical Systems lays off 125

Healthcare Dive

4 months ago

Prospect Medical Systems lays off 125

2 Healthcare Stocks with Competitive Advantages and 1 to Keep Off Your Radar

StockStory

4 months ago

2 Healthcare Stocks with Competitive Advantages and 1 to Keep Off Your Radar

Should You Investigate Astrana Health, Inc. (NASDAQ:ASTH) At US$26.70?

Simply Wall St.

4 months ago

Should You Investigate Astrana Health, Inc. (NASDAQ:ASTH) At US$26.70?

Argus Research

4 months ago

ASTH: Raising target price to $21.00

Argus Research

4 months ago

ASTH: Raising target price to $21.00

3 Growth Companies With High Insider Ownership And Up To 115% Earnings Growth

Simply Wall St.

4 months ago

3 Growth Companies With High Insider Ownership And Up To 115% Earnings Growth

Astrana Health's (NASDAQ:ASTH one-year decrease in earnings delivers investors with a 39% loss

Simply Wall St.

5 months ago

Astrana Health's (NASDAQ:ASTH one-year decrease in earnings delivers investors with a 39% loss

Argus Research

5 months ago

ASTH: Raising target price to $22.00

Argus Research

5 months ago

ASTH: Lowering target price to $21.00

Astrana Health Inc (ASTH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

GuruFocus.com

5 months ago

Astrana Health Inc (ASTH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

High Insider Ownership Growth Stocks To Watch In May 2025

Simply Wall St.

5 months ago

High Insider Ownership Growth Stocks To Watch In May 2025

Argus Research

5 months ago

ASTH: Raising target price to $26.00

Argus Research

6 months ago

ASTH: Lowering target price to $24.00

Argus Research

6 months ago

ASTH: Raising target price to $27.00

Astrana Health, Inc. Schedules 2025 First Quarter Financial Results Release and Conference Call

PR Newswire

6 months ago

Astrana Health, Inc. Schedules 2025 First Quarter Financial Results Release and Conference Call

Argus Research

6 months ago

ASTH: Raising target price to $25.00

3 Growth Companies Insiders Back With Up To 21% Revenue Growth

Simply Wall St.

6 months ago

3 Growth Companies Insiders Back With Up To 21% Revenue Growth

Argus Research

6 months ago

ASTH: Lowering target price to $24.00

Argus Research

7 months ago

ASTH: Lowering target price to $25.00

Insider Favorites For Growth In March 2025

Simply Wall St.

7 months ago

Insider Favorites For Growth In March 2025

Argus Research

7 months ago

ASTH: Lowering target price to $21.00

Astrana Health Inc (ASTH) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

GuruFocus.com

8 months ago

Astrana Health Inc (ASTH) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

Astrana Health, Inc. to Participate in Upcoming Investor Conferences

PR Newswire

8 months ago

Astrana Health, Inc. to Participate in Upcoming Investor Conferences

Argus Research

8 months ago

ASTH: Lowering target price to $28.00

CVS Health Stock Gets RS Rating Upgrade

Investor's Business Daily

8 months ago

CVS Health Stock Gets RS Rating Upgrade

Argus Research

8 months ago

ASTH: Raising target price to $35.00

Is Astrana Health, Inc.'s (NASDAQ:ASTH) Latest Stock Performance A Reflection Of Its Financial Health?

Simply Wall St.

8 months ago

Is Astrana Health, Inc.'s (NASDAQ:ASTH) Latest Stock Performance A Reflection Of Its Financial Health?

Argus Research

8 months ago

ASTH: Lowering target price to $39.00

Argus Research

9 months ago

ASTH: Raising target price to $40.00

Astrana Health repurchases 300,000 shares

TipRanks

9 months ago

Astrana Health repurchases 300,000 shares

Argus Research

9 months ago

ASTH: Raising target price to $39.00

Astrana Health, Inc. Announces Share Repurchase of 300,000 Shares

PR Newswire

9 months ago

Astrana Health, Inc. Announces Share Repurchase of 300,000 Shares

Is Astrana Health, Inc. (NASDAQ:ASTH) Potentially Undervalued?

Simply Wall St.

9 months ago

Is Astrana Health, Inc. (NASDAQ:ASTH) Potentially Undervalued?

Argus Research

9 months ago

ASTH: What does Argus have to say about ASTH?

Prospect Medical Explores Restructuring

The Wall Street Journal

9 months ago

Prospect Medical Explores Restructuring

With 52% ownership, Astrana Health, Inc. (NASDAQ:ASTH) boasts of strong institutional backing

Simply Wall St.

10 months ago

With 52% ownership, Astrana Health, Inc. (NASDAQ:ASTH) boasts of strong institutional backing

Argus Research

10 months ago

ASTH: Lowering target price to $35.00

Astrana Health, Inc. to Participate in Upcoming Investor Conference

PR Newswire

10 months ago

Astrana Health, Inc. to Participate in Upcoming Investor Conference

Argus Research

10 months ago

ASTH: Lowering target price to $37.00

Astrana Health (NASDAQ:ASTH) sheds 12% this week, as yearly returns fall more in line with earnings growth

Simply Wall St.

10 months ago

Astrana Health (NASDAQ:ASTH) sheds 12% this week, as yearly returns fall more in line with earnings growth

Argus Research

10 months ago

ASTH: Lowering target price to $41.00

Argus Research

10 months ago

ASTH: What does Argus have to say about ASTH?

3 US Growth Stocks With High Insider Ownership

Simply Wall St.

a year ago

3 US Growth Stocks With High Insider Ownership

Astrana Health Provider Groups Recognized with Highest Elite Status in America's Physician Groups 2024 Standards of Excellence™ Survey

PR Newswire

a year ago

Astrana Health Provider Groups Recognized with Highest Elite Status in America's Physician Groups 2024 Standards of Excellence™ Survey

Investors Shouldn't Be Too Comfortable With Astrana Health's (NASDAQ:ASTH) Earnings

Simply Wall St.

a year ago

Investors Shouldn't Be Too Comfortable With Astrana Health's (NASDAQ:ASTH) Earnings

Argus Research

a year ago

ASTH: Lowering target price to $45.00

Analyst Estimates: Here's What Brokers Think Of Astrana Health, Inc. (NASDAQ:ASTH) After Its Third-Quarter Report

Simply Wall St.

a year ago

Analyst Estimates: Here's What Brokers Think Of Astrana Health, Inc. (NASDAQ:ASTH) After Its Third-Quarter Report

Astrana Health Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a year ago

Astrana Health Third Quarter 2024 Earnings: Beats Expectations

Astrana Health Inc (ASTH) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Profit Challenges

GuruFocus.com

a year ago

Astrana Health Inc (ASTH) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Profit Challenges

Astrana Health Announces Definitive Agreement to Acquire Certain Businesses and Assets of Prospect Health System

PR Newswire

a year ago

Astrana Health Announces Definitive Agreement to Acquire Certain Businesses and Assets of Prospect Health System

Astrana Health, Inc. Reports Third Quarter 2024 Results

PR Newswire

a year ago

Astrana Health, Inc. Reports Third Quarter 2024 Results

Argus Research

a year ago

ASTH: What does Argus have to say about ASTH?

Astrana Health, Inc. Schedules 2024 Third Quarter Financial Results Release and Conference Call

PR Newswire

a year ago

Astrana Health, Inc. Schedules 2024 Third Quarter Financial Results Release and Conference Call

Astrana Health Inc (ASTH) Q2 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ...

GuruFocus.com

a year ago

Astrana Health Inc (ASTH) Q2 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ...

Argus Research

a year ago

ASTH: Raising target price to $62.00

Be Wary Of Astrana Health (NASDAQ:ASTH) And Its Returns On Capital

Simply Wall St.

a year ago

Be Wary Of Astrana Health (NASDAQ:ASTH) And Its Returns On Capital

Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 23% Discount?

Simply Wall St.

a year ago

Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 23% Discount?

Is Astrana Health, Inc.'s (NASDAQ:ASTH) Latest Stock Performance A Reflection Of Its Financial Health?

Simply Wall St.

a year ago

Is Astrana Health, Inc.'s (NASDAQ:ASTH) Latest Stock Performance A Reflection Of Its Financial Health?

Argus Research

a year ago

ASTH: Raising target price to $51.00

Argus Research

a year ago

ASTH: Raising target price to $50.00

Astrana Health's (NASDAQ:ASTH) Strong Earnings Are Of Good Quality

Simply Wall St.

a year ago

Astrana Health's (NASDAQ:ASTH) Strong Earnings Are Of Good Quality

Astrana Health Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a year ago

Astrana Health Second Quarter 2024 Earnings: Beats Expectations

Argus Research

a year ago

ASTH: Raising target price to $54.00

Astrana Health, Inc. Schedules 2024 Second Quarter Financial Results Release and Conference Call

PR Newswire

a year ago

Astrana Health, Inc. Schedules 2024 Second Quarter Financial Results Release and Conference Call

Astrana Health and Elation Health Form Nationwide Partnership to Expand Sustainable Support Infrastructure for Primary Care Physicians

PR Newswire

a year ago

Astrana Health and Elation Health Form Nationwide Partnership to Expand Sustainable Support Infrastructure for Primary Care Physicians

Astrana Health, Inc.'s (NASDAQ:ASTH) high institutional ownership speaks for itself as stock continues to impress, up 33% over last week

Simply Wall St.

a year ago

Astrana Health, Inc.'s (NASDAQ:ASTH) high institutional ownership speaks for itself as stock continues to impress, up 33% over last week

Argus Research

a year ago

ASTH: Raising target price to $53.00

Astrana Health and Anthem Blue Cross Establish Partnership to Deliver High-Quality Coordinated Care

PR Newswire

a year ago

Astrana Health and Anthem Blue Cross Establish Partnership to Deliver High-Quality Coordinated Care

Argus Research

a year ago

ASTH: Lowering target price to $40.00

Astrana Health's (NASDAQ:ASTH) five-year earnings growth trails the solid shareholder returns

Simply Wall St.

a year ago

Astrana Health's (NASDAQ:ASTH) five-year earnings growth trails the solid shareholder returns

Astrana Health, Inc. to Participate in Upcoming Investor Conferences

PR Newswire

a year ago

Astrana Health, Inc. to Participate in Upcoming Investor Conferences

Insider-Owned US Growth Companies To Watch In May 2024

Simply Wall St.

a year ago

Insider-Owned US Growth Companies To Watch In May 2024

Astrana Health, Inc. to Participate in Upcoming Investor Conference

PR Newswire

a year ago

Astrana Health, Inc. to Participate in Upcoming Investor Conference

Astrana Health First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

Astrana Health First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Astrana Health, Inc. (NASDAQ:ASTH) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Astrana Health, Inc. (NASDAQ:ASTH) Q1 2024 Earnings Call Transcript

Astrana Health Inc (ASTH) Reports Robust First Quarter 2024 Results with Significant Growth in ...

GuruFocus.com

a year ago

Astrana Health Inc (ASTH) Reports Robust First Quarter 2024 Results with Significant Growth in ...

Astrana Health, Inc. Reports First Quarter 2024 Results

PR Newswire

a year ago

Astrana Health, Inc. Reports First Quarter 2024 Results

Astrana Health, Inc. Schedules 2024 First Quarter Financial Results Release and Conference Call

PR Newswire

a year ago

Astrana Health, Inc. Schedules 2024 First Quarter Financial Results Release and Conference Call

Argus Research

a year ago

ASTH: Lowering target price to $39.00

Investors Could Be Concerned With Astrana Health's (NASDAQ:ASTH) Returns On Capital

Simply Wall St.

a year ago

Investors Could Be Concerned With Astrana Health's (NASDAQ:ASTH) Returns On Capital

Astrana Health, Inc. (NASDAQ:ASTH) Shares Could Be 50% Below Their Intrinsic Value Estimate

Simply Wall St.

2 years ago

Astrana Health, Inc. (NASDAQ:ASTH) Shares Could Be 50% Below Their Intrinsic Value Estimate

Astrana Health, Inc. Completes Acquisition of Community Family Care Medical Group IPA, Inc. and Health Plan

PR Newswire

2 years ago

Astrana Health, Inc. Completes Acquisition of Community Family Care Medical Group IPA, Inc. and Health Plan

Astrana Health, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

PR Newswire

2 years ago

Astrana Health, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

Astrana Health, Inc.'s (NASDAQ:ASTH) Stock Is Going Strong: Is the Market Following Fundamentals?

Simply Wall St.

2 years ago

Astrana Health, Inc.'s (NASDAQ:ASTH) Stock Is Going Strong: Is the Market Following Fundamentals?

Astrana Health, Inc. to Participate in Upcoming Investor Conference

PR Newswire

2 years ago

Astrana Health, Inc. to Participate in Upcoming Investor Conference

Astrana Health, Inc. Just Beat EPS By 9.3%: Here's What Analysts Think Will Happen Next

Simply Wall St.

2 years ago

Astrana Health, Inc. Just Beat EPS By 9.3%: Here's What Analysts Think Will Happen Next

Astrana Health Full Year 2023 Earnings: EPS Beats Expectations

Simply Wall St.

2 years ago

Astrana Health Full Year 2023 Earnings: EPS Beats Expectations

Astrana Health Inc (ASTH) Reports Growth in Revenue and Net Income for Q4 and Full Year 2023

GuruFocus.com

2 years ago

Astrana Health Inc (ASTH) Reports Growth in Revenue and Net Income for Q4 and Full Year 2023

Astrana Health, Inc. Reports Fourth Quarter and Year-End 2023 Results

PR Newswire

2 years ago

Astrana Health, Inc. Reports Fourth Quarter and Year-End 2023 Results

The 3 Most Popular Stocks Owned by Congress in Q1

InvestorPlace

2 years ago

The 3 Most Popular Stocks Owned by Congress in Q1

Share on Social Networks: